TNYA
Tenaya Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology · US
$0.67
−0.27%Sep 14, 2026, 12:30 UTC
The U.S. FDA granted Regenerative Medicine Advanced Therapy (RMAT) designation to Tenaya Therapeutics' TN-401 for the treatment of PKP2-associated arrhythmogenic right ventricular cardiomyopathy.
Source:Jul 15, 2026, 01:00 UTC
Tenaya Therapeutics granted stock options to its newly appointed CFO Eric Hyllengren and two new non-executive employees upon their employment commencement.
Source: